We are live on ! Find out more
TC

TFS Capital Portfolio holdings

AUM $255M
1-Year Est. Return 32.31%
This Fund
S&P 500
This Quarter Est. Return
+5.75%
1 Year Est. Return
+32.31%
3 Year Est. Return
+53.79%
5 Year Est. Return
10 Year Est. Return
AUM
$929M
AUM Growth
-$109M
Cap. Flow
-$118M
Cap. Flow %
-12.66%
Top 10 Hldgs %
7.01%
Holding
1,130
New
256
Increased
201
Reduced
274
Closed
399

Top Buys

Rank Stock Value
1
UPBD icon
Upbound Group
UPBD
+$7.28M
2
RAIL icon
FreightCar America
RAIL
+$5.96M
3
CPHD
Cepheid Inc
CPHD
+$5.77M
4
DBRG icon
DigitalBridge
DBRG
+$5.69M
5
SPXC icon
SPX Corp
SPXC
+$5.56M

Sector Composition

Rank Sector Weight
1 Healthcare 22.43%
2 Technology 14.1%
3 Industrials 13.01%
4 Consumer Discretionary 12.84%
5 Financials 6.69%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AVEO
1001
DELISTED
AVEO Pharmaceuticals, Inc.
AVEO
-11,162
Closed -$135K
IPHS
1002
DELISTED
Innophos Holdings, Inc.
IPHS
-11,107
Closed -$440K
CBPX
1003
DELISTED
CONTINENTAL BUILDING PRODUCTS, INC.
CBPX
-20,937
Closed -$430K
ARQL
1004
DELISTED
Arqule Inc
ARQL
-12,470
Closed -$23K
HOS
1005
DELISTED
Hornbeck Offshore Services, Inc.
HOS
-114,287
Closed -$1.55M
ASNA
1006
DELISTED
Ascena Retail Group, Inc.
ASNA
-10,639
Closed -$2.96M
CBM
1007
DELISTED
Cambrex Corporation
CBM
-89,874
Closed -$3.57M
LOR
1008
DELISTED
Lazard World Dividend & Income Fund, Inc.
LOR
-11,700
Closed -$107K
CVRS
1009
DELISTED
CORINDUS VASCULAR ROBOTICS, INC
CVRS
-65,891
Closed -$204K
ALDR
1010
DELISTED
Alder Biopharmaceuticals
ALDR
-15,354
Closed -$503K
NCI
1011
DELISTED
Navigant Consulting, Inc.
NCI
-16,351
Closed -$260K
TYPE
1012
DELISTED
Monotype Imaging Holdings Inc.
TYPE
-20,494
Closed -$447K
EMCI
1013
DELISTED
EMC INS Group Inc
EMCI
-18,755
Closed -$435K
FRED
1014
DELISTED
Fred's Inc
FRED
-134,846
Closed -$1.6M
ARRY
1015
DELISTED
Array Biopharma Inc
ARRY
-120,612
Closed -$550K
HF
1016
DELISTED
HFF Inc.
HF
-13,494
Closed -$456K
INSY
1017
DELISTED
Insys Therapeutics, Inc.
INSY
-38,098
Closed -$1.08M
EPE
1018
DELISTED
EP Energy Corporation
EPE
-160,237
Closed -$825K
GNCA
1019
DELISTED
Genocea Biosciences, Inc.
GNCA
-3,488
Closed -$191K
BRS
1020
DELISTED
Bristow Group, Inc.
BRS
-50,457
Closed -$1.32M
AKAO
1021
DELISTED
Achaogen Inc
AKAO
-11,805
Closed -$68K
RDC
1022
DELISTED
Rowan Companies Plc
RDC
-41,187
Closed -$665K
ACET
1023
DELISTED
Aceto Corp
ACET
-16,835
Closed -$462K
ICON
1024
DELISTED
Iconix Brand Group, Inc.
ICON
-1,775
Closed -$240K
ELGX
1025
DELISTED
Endologix Inc
ELGX
-1,212
Closed -$149K

Similar funds

TFS Capital's Q4 2015 Portfolio in Review

As of Q4 2015, TFS Capital held 1,130 positions worth $929M, down 10% from $1.04B the previous quarter. Its ten largest holdings account for 7% of the portfolio.

TFS Capital withdrew a net $118M in Q4 2015, closing 399 positions and reducing 274 holdings. Its most notable exit was ePlus, an estimated $7.35M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 22% of assets, up from 18% a quarter earlier, followed by Technology and Industrials.

Against the trend, TFS Capital opened a new position in Upbound Group worth $5.71M.

  • TFS Capital's largest Q4 2015 buy was Upbound Group: 381,410 shares worth $5.71M.
  • TFS Capital added most to SPX Corp in Q4 2015, an estimated $5.56M increase.
  • TFS Capital's biggest Q4 2015 reduction was Concert Pharmaceuticals, Inc., cutting an estimated $6.04M.
  • TFS Capital fully exited ePlus in Q4 2015, selling an estimated $7.35M.
  • TFS Capital's ten largest holdings make up 7% of its $929M portfolio in Q4 2015.
  • TFS Capital opened 256 new positions and closed 399 in Q4 2015.
  • TFS Capital's portfolio value fell 10% quarter-over-quarter to $929M.

Based on TFS Capital's 13F filing for Q4 2015, filed 29 Jan 2016.